Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Catapres 100microgram tablets
0205020E0BBAAAC
|
Catapres | Clonidine hydrochloride | Cardiovascular System | 736 |
|
Catapres TTS 1 patches
0205020E0BBAEAF
|
Catapres | Clonidine hydrochloride | Cardiovascular System | 12 |
|
Catapres 150micrograms/1ml solution for injection ampoules
0205020E0BBADAB
|
Catapres | Clonidine hydrochloride | Cardiovascular System | 1 |
|
Catapres TTS 2 patches
0205020E0BBAFAG
|
Catapres | Clonidine hydrochloride | Cardiovascular System | 1 |
|
Catapres 300microgram tablets
0205020E0BBABAD
|
Catapres | Clonidine hydrochloride | Cardiovascular System | No data available |
|
Catapres PL Perlongets 250microgram capsules
0205020E0BBACAA
|
Catapres | Clonidine hydrochloride | Cardiovascular System | No data available |
|
Catapres TTS 3 patches
0205020E0BBAGAH
|
Catapres | Clonidine hydrochloride | Cardiovascular System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.